Participant flow

Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma · Source last updated 2021-11-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Minocycline 100 mg (capsule) two times a day to begin with start of maintenance therapy (3 months +/- 2 days)

   id

   FG000

   title

   Minocycline

2. description

   Placebo 100 mg (capsule) two times a day to begin with start of maintenance therapy (3 months +/- 2 days)

   id

   FG001

   title

   Placebo

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         6

      2. group Id

         FG001

         num Subjects

         4

      type

      Withdrawal by Subject

   2. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         2

      type

      Adverse Event

   3. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      type

      Too ill to continue

   4. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         1

      type

      Switched chemo

   5. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      type

      Lack of compliance

   6. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         1

      type

      Requested to be removed from the study

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         43

      2. group Id

         FG001

         num Subjects

         44

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         33

      2. group Id

         FG001

         num Subjects

         36

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         10

      2. group Id

         FG001

         num Subjects

         8

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

88 participants enrolled and randomized to either the intervention group or the control group. 1 patient withdrew before the study began.

recruitment Details

All recruitment done at the University of Texas MD Anderson Cancer

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice